CTI Trademark

Trademark Overview


On Tuesday, July 27, 2021, a trademark application was filed for CTI with the United States Patent and Trademark Office. The USPTO has given the CTI trademark a serial number of 90851461. The federal status of this trademark filing is REGISTERED as of Tuesday, October 24, 2023. This trademark is owned by CTI Biopharma Corp.. The CTI trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing healthcare information regarding disease states and treatments to healthcare professionals and patients

Research and development of pharmaceutical preparations; product research and development for others in the field of pharmaceutical preparations; product research and development services, namely, assessing intended target recipients of pharmaceutical preparations and positioning pharmaceutical preparations for success in clinical development and commercial use; providing technical consultation in the field of pharmaceutical product research and development
cti

General Information


Serial Number90851461
Word MarkCTI
Filing DateTuesday, July 27, 2021
Status700 - REGISTERED
Status DateTuesday, October 24, 2023
Registration Number7202661
Registration DateTuesday, October 24, 2023
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 13, 2022

Trademark Statements


Description of MarkThe mark consists of the letters "CTI" with six dots above the "I" in the shape of an "X".
Pseudo MarkCTI X
Pseudo MarkCTIX
Goods and ServicesProviding healthcare information regarding disease states and treatments to healthcare professionals and patients
Goods and ServicesResearch and development of pharmaceutical preparations; product research and development for others in the field of pharmaceutical preparations; product research and development services, namely, assessing intended target recipients of pharmaceutical preparations and positioning pharmaceutical preparations for success in clinical development and commercial use; providing technical consultation in the field of pharmaceutical product research and development

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 24, 2021
Primary Code042
First Use Anywhere DateThursday, October 14, 2021
First Use In Commerce DateThursday, October 14, 2021

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 24, 2021
Primary Code044
First Use Anywhere DateThursday, March 31, 2022
First Use In Commerce DateThursday, March 31, 2022

Trademark Owner History


Party NameSOBI, INC
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressWALTHAM, MA 02451

Party NameCTI Biopharma Corp.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98121

Party NameCTI Biopharma Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98121

Party NameCTI Biopharma Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98121

Trademark Events


Event DateEvent Description
Friday, July 30, 2021NEW APPLICATION ENTERED
Friday, September 24, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 25, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, April 21, 2022ASSIGNED TO EXAMINER
Friday, April 29, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, April 29, 2022EXAMINERS AMENDMENT E-MAILED
Friday, April 29, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, April 29, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, May 3, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 10, 2022PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, May 10, 2022WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
Tuesday, May 31, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 31, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 31, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 9, 2022NON-FINAL ACTION WRITTEN
Thursday, June 9, 2022NON-FINAL ACTION E-MAILED
Thursday, June 9, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 8, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 8, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, July 9, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 11, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 24, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 13, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 8, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, April 28, 2023SOU TEAS EXTENSION RECEIVED
Friday, April 28, 2023SOU EXTENSION 1 FILED
Friday, April 28, 2023SOU EXTENSION 1 GRANTED
Tuesday, May 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 3, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, August 3, 2023USE AMENDMENT FILED
Monday, August 14, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 14, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, September 18, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 19, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 24, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 24, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, October 16, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP